首页> 外文OA文献 >Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors
【2h】

Loss of Heterozygosities in Five Tumor Suppressor Genes (FHIT Gene, p16, pRb, E-Cadherin and p53) in Thyroid Tumors

机译:在甲状腺肿瘤中失去五种肿瘤抑制基因(FHIT基因,P16,PRB,E-CADHERIN和P53)中的杂合子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

ObjectivesTo evaluate the loss of heterozygosities (LOH) of chromosomes 3p14 (FHIT gene), 9p21 (p16), 13q21 (pRb), 6q22 (E-cadherin) and 17p13 (p53) in various thyroid tumors.MethodsEighty thyroid tumor cases (20 follicular adenomas, 10 follicular carcinomas, and 50 papillary carcinomas) have been analyzed for the presence of LOH in chromosomes 3p14, 9p21, 13q21, 6q22, and 17p13 allelic loss, using microsatellite markers and DNA obtained from formalin-fixed paraffin-embedded archival tissues.ResultsLOH on 3p14 was found in 10.5%, 33.3%, and 30.4% of follicular adenomas, follicular carcinomas, and papillary carcinomas, respectively. LOH on 9p21 was detected in 6%, 44.4%, and 47.8%, respectively. LOH on pRb gene was found in 5.3%, 20.0%, and 35.4%, respectively. LOH on E-cadherin gene was found in 5.3%, 22.2%, and 43.8%, respectively. LOH on 17p13 was detected in 0%, 40%, and 45.8%, respectively. LOH in FHIT gene, p16, pRb, E-cadherin, and p53 genes were more frequently identified in follicular carcinoma and papillary carcinoma than in follicular adenoma.ConclusionLOH results of the five tumor suppressor genes (FHIT gene, p16, pRb, E-cadherin, and p53) showed statistical differences between benign tumor and malignant tumor. Among papillary carcinoma, LOH in p16, E-cadherin and p53 genes well correlated with poorly differentiated grade, and LOH of E-cadherin was associated with lymph node metastasis.
机译:Objectivesto评估染色体3p14(Fhit基因),9p21(p16),13q 21(prb),6q22(e-cadherin)和17p13(p53)在各种甲状腺肿瘤中的杂种术(LOH)的丧失。甲状腺瘤病例(20卵泡已经分析了腺瘤,10个卵泡癌和50个乳头状癌,用于使用从福尔马林固定的石蜡包埋的归档组织中获得的微卫星标记和DNA的染色体3p14,9p21,11321,6q22和17p13等位基因损失。 3P14的结果分别在10.5%,33.3%和30.4%的卵泡腺瘤,滤泡癌和乳头状癌中发现。在9p21上的LOH分别检测为6%,44.4%和47.8%。 PRB基因的LOH分别在5.3%,20.0%和35.4%中发现。 e-cadherin基因上的LOH分别以5.3%,22.2%和43.8%的43.8%。 17P13的LOH分别检测为0%,40%和45.8%。 LOH在FHIT基因中,P16,PRB,E-CDADHERIN和P53基因在滤泡癌和乳头状癌中更常见,而不是在卵泡腺瘤中鉴定在卵泡腺瘤中。五种肿瘤抑制基因的愈合载体(FHIT基因,P16,PRB,E-CADHERIN和p53)显示出良性肿瘤和恶性肿瘤之间的统计差异。在P16中的乳头状癌,LOH,e-cadherin和p53基因与淋巴结转移相关的良好分化的等级差和e-cadherin的LOH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号